Galectin Therapeutics Inc. (GALT)

[biotech2010]

I would just like to see someone else just once say 'I was wrong' about GALT. I did that last September when it became clear to me that Traber was incompetent. Instead I get a former pumper tell me to read a filing that says exactly what I posted here months ago (that there was no partner on the horizon).

As for everything else, I haven't given up on the CX trial being a success and will most likely buy an equal amount of January calls once the July options are near expiration By then the share price will likely be under $2 with Uihlein selling up to 2M shares on the open market.

There is nothing good about this new secondary, the ATM arrangement, as it did the last time, will kill the stock every time it starts to get some momentum and Traber needs some new Elvis sport coats and suits. I guess it never occurred to Traber and crew to take some pay cuts for the rest of the year and conserve enough cash so that they could do a new secondary after the CX trial was a success. Of course, if it fails, the company is history and someone will buy the galectin technology for almost nothing so what difference does it make.